BQ-788

BQ-788 · MelCure SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BQ-788, covering 2015-05-20 to 2015-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma [EARLY_Phase 1]